Trupanion, Inc. TRUP
We take great care to ensure that the data presented and summarized in this overview for TRUPANION, INC. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding TRUP
View all-
Black Rock Inc. New York, NY5.45MShares$197 Million0.0% of portfolio
-
Capital World Investors Los Angeles, CA4.1MShares$148 Million0.03% of portfolio
-
Aflac Inc3.64MShares$131 Million99.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.6MShares$130 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA2.2MShares$79.4 Million0.02% of portfolio
-
State Street Corp Boston, MA1.29MShares$46.7 Million0.0% of portfolio
-
Polar Capital Holdings PLC London, X01.25MShares$45.1 Million0.37% of portfolio
-
Morgan Stanley New York, NY966KShares$34.9 Million0.0% of portfolio
-
Josh Tarasoff Greenlea Lane Capital Management, LLC | Weston, Ct934KShares$33.7 Million16.39% of portfolio
-
Marshall Wace, LLP London, X0902KShares$32.5 Million0.06% of portfolio
Latest Institutional Activity in TRUP
Top Purchases
Top Sells
About TRUP
Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Puerto Rico, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians. The company was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013. The company was founded in 2000 and is headquartered in Seattle, Washington.
Insider Transactions at TRUP
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 27
2025
|
Fawwad Qureshi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,416
-100.0%
|
$79,728
$33.88 P/Share
|
Mar 07
2025
|
John R Gallagher Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,100
-10.82%
|
$99,200
$32.99 P/Share
|
Mar 07
2025
|
Brenna Mcgibney Chief Administration Officer |
SELL
Open market or private sale
|
Direct |
5,000
-57.22%
|
$160,000
$32.99 P/Share
|
Mar 07
2025
|
Emily Dreyer SVP, Channel Growth |
SELL
Open market or private sale
|
Direct |
14,025
-18.22%
|
$448,800
$32.41 P/Share
|
Mar 07
2025
|
Emily Dreyer SVP, Channel Growth |
BUY
Exercise of conversion of derivative security
|
Direct |
10,654
+6.35%
|
$149,156
$14.31 P/Share
|
Mar 04
2025
|
Margaret Tooth CEO |
SELL
Open market or private sale
|
Direct |
2,294
-1.89%
|
$71,114
$31.39 P/Share
|
Feb 27
2025
|
Margaret Tooth CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,140
-1.74%
|
$70,620
$33.59 P/Share
|
Feb 27
2025
|
Margaret Tooth CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,790
+6.66%
|
-
|
Feb 26
2025
|
Fawwad Qureshi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,373
-36.24%
|
$46,682
$34.22 P/Share
|
Feb 25
2025
|
Steve Weinrauch EVP, North Am & Vet Strategy |
SELL
Payment of exercise price or tax liability
|
Direct |
619
-0.23%
|
$21,046
$34.12 P/Share
|
Feb 25
2025
|
Steve Weinrauch EVP, North Am & Vet Strategy |
BUY
Exercise of conversion of derivative security
|
Direct |
2,095
+0.75%
|
-
|
Feb 25
2025
|
Brenna Mcgibney Chief Administration Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
344
-0.78%
|
$11,696
$34.12 P/Share
|
Feb 25
2025
|
Brenna Mcgibney Chief Administration Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
647
+1.43%
|
-
|
Feb 25
2025
|
Jason Wasdin General Manager |
SELL
Payment of exercise price or tax liability
|
Direct |
59
-0.43%
|
$2,006
$34.12 P/Share
|
Feb 25
2025
|
Jason Wasdin General Manager |
BUY
Exercise of conversion of derivative security
|
Direct |
202
+1.45%
|
-
|
Feb 25
2025
|
Emily Dreyer SVP, Channel Growth |
SELL
Payment of exercise price or tax liability
|
Direct |
730
-0.59%
|
$24,820
$34.12 P/Share
|
Feb 25
2025
|
Emily Dreyer SVP, Channel Growth |
BUY
Exercise of conversion of derivative security
|
Direct |
2,648
+2.08%
|
-
|
Feb 25
2025
|
Darryl Rawlings Director |
SELL
Payment of exercise price or tax liability
|
Direct |
896
-0.07%
|
$30,464
$34.12 P/Share
|
Feb 25
2025
|
Darryl Rawlings Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,684
+0.28%
|
-
|
Feb 25
2025
|
John R Gallagher Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
567
-0.33%
|
$19,278
$34.12 P/Share
|
Last 12 Months Summary
Exercise of conversion of derivative security | 295K shares |
---|---|
Open market or private purchase | 20.7K shares |
Open market or private sale | 77.9K shares |
---|---|
Payment of exercise price or tax liability | 79.2K shares |